Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 27% ± 9% | |
kidney | 6 studies | 27% ± 9% | |
intestine | 5 studies | 27% ± 12% | |
uterus | 5 studies | 47% ± 16% | |
eye | 4 studies | 28% ± 15% | |
skin | 4 studies | 38% ± 13% | |
breast | 4 studies | 32% ± 9% | |
peripheral blood | 3 studies | 20% ± 1% | |
adrenal gland | 3 studies | 23% ± 6% | |
lymph node | 3 studies | 22% ± 4% | |
brain | 3 studies | 28% ± 6% | |
liver | 3 studies | 17% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 31390.78 | 233 / 245 | 98% | 168.83 | 494 / 502 |
lung | 92% | 26917.92 | 532 / 578 | 70% | 38.37 | 803 / 1155 |
thymus | 82% | 30518.33 | 536 / 653 | 77% | 74.76 | 466 / 605 |
adrenal gland | 67% | 24370.58 | 174 / 258 | 89% | 143.54 | 204 / 230 |
ovary | 98% | 83623.07 | 177 / 180 | 55% | 30.15 | 238 / 430 |
bladder | 86% | 15566.10 | 18 / 21 | 61% | 31.93 | 309 / 504 |
skin | 55% | 10869.04 | 995 / 1809 | 88% | 47.83 | 414 / 472 |
intestine | 59% | 15227.96 | 572 / 966 | 83% | 48.55 | 436 / 527 |
stomach | 56% | 18908.47 | 202 / 359 | 84% | 42.71 | 240 / 286 |
breast | 80% | 21627.94 | 368 / 459 | 57% | 29.50 | 637 / 1118 |
kidney | 60% | 16179.82 | 53 / 89 | 65% | 58.21 | 586 / 901 |
esophagus | 49% | 13304.61 | 708 / 1445 | 74% | 46.27 | 136 / 183 |
uterus | 62% | 14709.09 | 105 / 170 | 51% | 24.90 | 236 / 459 |
eye | 0% | 0 | 0 / 0 | 100% | 65.40 | 80 / 80 |
pancreas | 17% | 2087.23 | 55 / 328 | 78% | 47.19 | 138 / 178 |
blood vessel | 94% | 44203.03 | 1250 / 1335 | 0% | 0 | 0 / 0 |
adipose | 89% | 38336.03 | 1076 / 1204 | 0% | 0 | 0 / 0 |
muscle | 81% | 15396.91 | 654 / 803 | 0% | 0 | 0 / 0 |
heart | 72% | 30097.23 | 619 / 861 | 0% | 0 | 0 / 0 |
brain | 16% | 2220.91 | 417 / 2642 | 47% | 14.57 | 329 / 705 |
liver | 28% | 3482.56 | 64 / 226 | 21% | 5.83 | 84 / 406 |
tonsil | 0% | 0 | 0 / 0 | 38% | 11.19 | 17 / 45 |
lymph node | 0% | 0 | 0 / 0 | 14% | 2.46 | 4 / 29 |
spleen | 12% | 1736.71 | 29 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 11% | 1027.93 | 104 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071376 | Biological process | cellular response to corticotropin-releasing hormone stimulus |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0061469 | Biological process | regulation of type B pancreatic cell proliferation |
GO_0006954 | Biological process | inflammatory response |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0035767 | Biological process | endothelial cell chemotaxis |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0160075 | Biological process | non-canonical inflammasome complex assembly |
GO_0006915 | Biological process | apoptotic process |
GO_0001975 | Biological process | response to amphetamine |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0014860 | Biological process | neurotransmitter secretion involved in regulation of skeletal muscle contraction |
GO_0032497 | Biological process | detection of lipopolysaccharide |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0098793 | Cellular component | presynapse |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0035259 | Molecular function | nuclear glucocorticoid receptor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0001530 | Molecular function | lipopolysaccharide binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR4A1 |
Protein name | Nuclear receptor subfamily 4 group A member 1 Nuclear receptor subfamily 4immunitygroup A member 1 (Early response protein NAK1) (Nuclear hormone receptor NUR/77) (Nur77) (Orphan nuclear receptor HMR) (Orphan nuclear receptor TR3) (ST-59) (Testicular receptor 3) |
Synonyms | HMR NAK1 GFRP1 |
Description | FUNCTION: Orphan nuclear receptor. Binds the NGFI-B response element (NBRE) 5'-AAAGGTCA-3' . Binds 9-cis-retinoic acid outside of its ligand-binding (NR LBD) domain . Participates in energy homeostasis by sequestrating the kinase STK11 in the nucleus, thereby attenuating cytoplasmic AMPK activation . Regulates the inflammatory response in macrophages by regulating metabolic adaptations during inflammation, including repressing the transcription of genes involved in the citric acid cycle (TCA) (By similarity). Inhibits NF-kappa-B signaling by binding to low-affinity NF-kappa-B binding sites, such as at the IL2 promoter . May act concomitantly with NR4A2 in regulating the expression of delayed-early genes during liver regeneration (By similarity). Plays a role in the vascular response to injury (By similarity). .; FUNCTION: In the cytosol, upon its detection of both bacterial lipopolysaccharide (LPS) and NBRE-containing mitochondrial DNA released by GSDMD pores during pyroptosis, it promotes non-canonical NLRP3 inflammasome activation by stimulating association of NLRP3 and NEK7. . FUNCTION: In the cytosol, upon its detection of both bacterial lipopolysaccharide (LPS) and NBRE-containing mitochondrial DNA released by GSDMD pores during pyroptosis, it promotes non-canonical NLRP3 inflammasome activation by stimulating association of NLRP3 and NEK7. . |
Accessions | ENST00000546842.5 ENST00000360284.7 [P22736-2] H3BT85 ENST00000545748.5 ENST00000243050.5 [P22736-1] ENST00000548232.1 [P22736-3] H3BQG5 ENST00000394825.6 [P22736-1] ENST00000548977.5 ENST00000562373.1 ENST00000550082.5 [P22736-2] ENST00000550582.2 H3BSM8 ENST00000550763.1 ENST00000553200.1 F5GXF0 P22736 F8VVX9 H3BSB9 H3BPN8 ENST00000394824.2 [P22736-1] |